Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Last year, two popular smartwatches—the Samsung Galaxy Watch and Apple Watch—received Food and Drug Administration approval ...

The ability to have an appointment with a doctor or other health care provider by video visit or telephone call has improved ...

Guidance: Abbott reaffirms full-year 2025 adjusted EPS of $5.05-$5.25 versus a consensus of $5.15, with organic sales growth ...

The U.S. Veterans Administration measures a substantial reduction in its carbon footprint associated with patient travel by ...

A screenshot from a video produced by the Department of Veterans Affairs for its weekly podcast series, The BLUF. (Department ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Troy Ita’s life was turned upside down by diabetes. Thankfully, he doesn’t have to compromise lifestyle or family time with ...

Smartwatches and fitness trackers are being used more for health monitoring. Virtual fitness and telehealth and mental health apps are emerging. Employers are creating wellness programs to ...